KU Leuven

Selected news for the capital firm - KU Leuven, collected since 10/2017. Recent stories appear in Phys Org and National Institutes of Health. This capital firm shares healthcare news with Boehringer Ingelheim, Merck, COVID-19 and many others.

Please provide a valid email address.

Selected Headines

Date Headline (link) Source Relevant Snippet
11/7/2020 The Prevalence of Undiagnosed Age-Related Sight-Threatening Diseases in Self-Proclaimed Healthy Individuals hindawi.com ... Tine Jacobs, 1 Ruben Van Landeghem, 1 Patrick De Boever, 3,5,6 and Ingeborg Stalmans1 Department of Ophthalmology, University Hospitals UZ Leuven, Herestraat 49, 3000 Leuven, Belgium2 Research Group Ophthalmology, Department of Neurosciences, KU Leuven , Herestraat 49, 3000 Leuven, Belgium3 Health Unit, VITO (Flemish Institute for Technological Research), Boeretang 200, 2400 Mol, Belgium4 Department of Ophthalmology, Centro Hospitalar SaÃÉo JoaÃÉo, Porto, Portugal5 Center of Environmental Sciences ...
11/4/2020 Rapid Adaptation in K-12: Technology at a Break-Neck Speed techlearning.com By Sean Wargo 04 November 2020 While most markets are reeling from the COVID-19 pandemic, K-12 education has seen the most disruption to its core service model. Shares Instructor uses Barco WeConnect technology in a hybrid virtual learning classroom at KU Leuven in Belgium (Image credit: KU Leuven )Here at the Audiovisual and Integrated Experience Association ( AVIXA ) we keep a watchful eye on the developments within what we ...
11/3/2020 Six years of measuring patient experiences in Belgium: Limited improvement and lack of association with improvement strategies plos.org ... Roles Formal analysis, Investigation, Methodology, Project administration, Visualization, Writing – original draft, Writing – review & editing E-mail: Kris Vanhaecht, Roles Funding acquisition, Supervision, Writing – review & editing Affiliations Leuven Institute for Healthcare Policy, KU Leuven —University of Leuven, Leuven, Flanders, Belgium, Department of Quality Improvement, University Hospitals Leuven, Leuven, Flanders, Belgium ⨯ Dirk De Ridder, Roles Funding acquisition, Supervision, Writing – review & editing Affiliations Leuven Institute for Healthcare Policy ...
11/2/2020 CSC IMEC KU Leuven Scholarships for Chinese Students in Belgium, 2020 scholarship-positions.com Home » Blog » CSC IMEC KU Leuven Scholarships for Chinese Students in Belgium, 2020 November 2, 2020 CSC IMEC KU Leuven Scholarships for Chinese Students in Belgium, 2020Tuition is on the rise nationwide, and scholarships give students access to higher education. Therefore, the China Scholarship Council (CSC), KU Leuven, and IMEC are jointly offering the CSC IMEC KU Leuven Scholarships programme.The main purpose of PhD degree Scholarships ...
10/31/2020 How the corona virus conquered the earth and on the way … newsy-today.com ... than the original that left Wuhan. Does that make us less likely to turn the pandemic around? Or to find a vaccine?At the end of March, the Leuven virologist Piet Maes (Rega Institute KU Leuven ) saw for the first time a new variant of the coronavirus emerging among the virus samples taken from Belgian covid patients … Share this ...
10/27/2020 ERS Congress Interview: Prof Greet Van den Berghe emjreviews.com ... terms of the Creative Commons Attribution-Non Commercial 4.0 License .Prof Greet Van den Berghe ERS Gold Medal in ARDS Winner Chair Intensive Care Medicine, UZ Leuven, and Head Laboratory of Intensive Care Medicine, KU Leuven , Leuven, Belgium What attracted you to specialise in the endocrinology of critical illness?When I was a junior attending physician in the intensive care unit (ICU), quite some time ago, I noticed that long ...
10/16/2020 Help from hamsters progressive-charlestown.com Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does KU Leuven Virologists from the KU Leuven Rega Institute in Belgium have shown that a treatment with the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. A high dose of the anti-flu drug favipiravir, by contrast, has an antiviral effect in the hamsters. The team published their findings in ...
10/14/2020 More than 5,000 infections per day on average world-today-news.com ... That figure, the incidence figure, currently reveals differences between Wallonia (586 per 100,000) and Brussels (800) on the one hand and Flanders (259) on the other. Already predicts professor of biostatistics Geert Molenberghs (UHasselt, KU Leuven ) that it is only a matter of time before Flanders follows Wallonia. ‘The universities in Flanders started a week later’ and the infections mainly occur in people in their twenties.The number of ...
10/14/2020 Anti-flu drug prevents coronavirus better than hydroxychloroquine blogspot.com ... Treatment with a high dose of the anti-flu drug favipiravir has been found to have a more potent antiviral effect than hydroxychloroquine in an animal experiment with the novel coronavirus. Virologists at the KU Leuven Rega Institute (KU Leuven) in Belgium have been testing existing drugs in search of a vaccine – they detected hardly any infectious virus particles in hamsters that received favipiravir even after exposure to an ...
10/14/2020 Drosophila Voltage-Gated Sodium Channels Are Only Expressed in Active Neurons and Are Localized to Distal Axonal Initial Segment-like Domains jneurosci.org ... Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030 2 Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, Texas 77030 3 VIB Center for Brain & Disease Research, KU Leuven , Leuven 3000, Belgium 4 Department of Human Genetics, KU Leuven , Leuven 3000, Belgium 1 Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030 2 Jan and Dan Duncan Neurological Research ...
10/13/2020 Existing flu medicine may be able to slow down corona – Wel.nl newsy-today.com ... that can help against the corona virus. Hamsters given a high dose of favipiravir were found to be much less ill. The much more famous drug hydroxychloroquine had no effect. This is reported by KU Leuven , which published the study in the professional journal PNAS.Favipiravir is a drug that is mainly used against the flu virus in Japan. The researchers administered the drug to infected hamsters. In the animals ...
10/13/2020 High Dose Of Favipiravir Counters SARS-CoV-2 In Hamsters science20.com ... starting point because the virus replicates itself strongly after infection. Hamsters also develop a lung pathology similar to mild COVID-19 in humans, which makes them superior to mice in humans. Image: Layla Aerts - KU Leuven For a new study, scientists gave hamsters either hydroxychloroquine or favipiravir - a broad-spectrum antiviral drug used in Japan to treat influenza - for four to five days. They tested several doses of favipiravir. The ...
10/13/2020 Favipiravir at excessive doses works to curb COVID-19 in hamsters, HCQ ineffective: Examine theholytime.com ... whereas hydroxychloroquine (HCQ) did not have an analogous impact. Antiviral medicine don’t destroy its goal pathogen however as an alternative, it inhibits the event of the virus within the physique.Virologists on the KU Leuven Rega Institute, Belgium have been testing to see which current drug can remedy/scale back the quantity of SARS-CoV-2 virus in an contaminated individual. For that objective, they’re conducting trials on ...
10/5/2020 Special Report on Metabolic Disease: Intercepting diabetes ddn-news.com ... patients about this so many times because they always ask us, why haven’t you cured this disease yet or why haven’t you prevented this disease yet?” recounts Chantal Mathieu, head of Clinical Endocrinology at KU Leuven and coordinator of INNODIA, a T1D public-private partnership. “I always say it’s not because of lack of trying.” She offers several reasons why T1D proves particularly challenging. Firstly, it affects such a small ...
9/26/2020 Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 - PubMed National Institutes of Health ... CIMI PARIS), AP-HP Hôpital Pitié-Salpêtrière, Paris, France. Translational Immunology Lab, Institut Pasteur, Paris, France. Laboratory for Inborn Errors of Immunity, Department of Microbiology, Immunology and Transplantation, Department of Pediatrics, University Hospitals Leuven, KU Leuven , Belgium. Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Sorbonne Université, UMS037, PASS, Plateforme de cytométrie de la Pitié-Salpêtrière CyPS, F-75013 Paris, France. Bioinformatics Platform, Structure ...